Ganoderic acid A ameliorates renal fibrosis by suppressing the expression of NPC1L1

被引:0
|
作者
Han, Tianyun [1 ]
Li, Zhong [1 ]
Zhang, Luoning [1 ]
Xie, Linshen [1 ]
机构
[1] Sichuan Univ, West China Hosp 4, West China Sch Publ Hlth, Dept Nephrol & Environm Occupat Hlth, Chengdu 610041, Peoples R China
关键词
Ganoderic acid A; Epithelial-mesenchymal transition; Renal fi brosis; Transcriptomics; TGF-(3; KIDNEY; CELLS; LEUCOCONTEXTUM; INHIBITION; PROTEIN;
D O I
10.32604/biocell.2024.055029
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Objective: The study aimed to explore the protective mechanism of Ganoderic acid A (GAA) in renal fibrosis and to verify that GAA can ameliorate renal fibrosis by regulating the Niemann-pick C1-like 1 (NPC1L1) gene. Methods: Transforming growth factor beta1 (TGF-(31) was used to treat Human Kidney-2 (HK-2) cells to establish a renal fibrosis model. The differentially expressed genes in the control (CTRL) group, TGF-(31 group, and TGF-(31 + GAA group were screened via transcriptome sequencing technology and verified by qPCR and Western blot experiments. The NPC1L1 gene overexpression plasmid was constructed. The expression levels of N-cad, E-cad, and Slug-related proteins in CTRL, TGF-(31, TGF-(31+GAA (25 mu g/mL), and TGF-(31+GAA (25 mu g/mL) + NPC1L1 Overexpression (OE) groups were detected by qPCR and Western blot analysis. Western blot analysis was used to identify the extracellular matrixassociated proteins Tenascin-C, a-SMA, and fibrosis-related protein Collagen I. Fibrosis marker protein Fibronectin was detected and quantified by immunofluorescence. Results: Transcriptomic sequencing revealed that TGF-(31 stimulation led to 267 differentially regulated genes, with 118 up-regulated and 149 down-regulated, while further modulation of 213 genes, comprising 112 up-regulated and 101 down-regulated genes, was observed in the GAA intervention group. The target gene in these processes was found to be NPC1L1 by investigations using Gene Ontology (GO) and the Kyoto Encyclopedia of Genes and Genomes (KEGG). qPCR and Western blot results confirmed that TGF-(31 increased NPC1L1 expression, which was attenuated by GAA. Additionally, TGF-(31 upregulated N-cad and Slug. However, GAA reversed this effect and NPC1L1 overexpression partially rescued the GAA effect. TGF-(31 also decreased E-cad expression, reversed by GAA, and NPC1L1 overexpression antagonized this reversal. Furthermore, TGF-(31 promoted Collagen I, a-SMA, and Tenascin-C expression, and GAA reduced these levels, effects that were reversed by NPC1L1 overexpression. Immunofluorescence results showed that TGF-(31 increased fibronectin expression, which was decreased by GAA, and increased by NPC1L1 overexpression. Conclusion: GAA ameliorates renal fibrosis by antagonizing NPC1L1 gene expression inhibiting epithelialmesenchymal transition and reducing extracellular matrix formation.
引用
收藏
页码:1625 / 1638
页数:14
相关论文
共 50 条
  • [1] Regulation of intestinal NPC1L1 expression by dietary fish oil and docosahexaenoic acid
    Mathur, Satya N.
    Watt, Kim R.
    Field, F. Jeffrey
    JOURNAL OF LIPID RESEARCH, 2007, 48 (02) : 395 - 404
  • [2] Human NPC1L1 Expression is Positively Regulated by PPARα
    Yuki Iwayanagi
    Tappei Takada
    Fumiya Tomura
    Yoshihide Yamanashi
    Tomohiro Terada
    Ken-ichi Inui
    Hiroshi Suzuki
    Pharmaceutical Research, 2011, 28 : 405 - 412
  • [3] Human NPC1L1 Expression is Positively Regulated by PPARα
    Iwayanagi, Yuki
    Takada, Tappei
    Tomura, Fumiya
    Yamanashi, Yoshihide
    Terada, Tomohiro
    Inui, Ken-ichi
    Suzuki, Hiroshi
    PHARMACEUTICAL RESEARCH, 2011, 28 (02) : 405 - 412
  • [4] The role of NPC1L1 in cancer
    Zhang, Renshuai
    Zeng, Jun
    Liu, Wenjing
    Meng, Jingsen
    Wang, Chao
    Shi, Lingyu
    Yang, Shanbo
    Chang, Jing
    Xing, Dongming
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [5] NPC1L1 and cholesterol transport
    Betters, Jenna L.
    Yu, Liqing
    FEBS LETTERS, 2010, 584 (13): : 2740 - 2747
  • [6] Atorvastatin increases intestinal expression of NPC1L1 in hyperlipidemic men
    Tremblay, Andre J.
    Lamarche, Benoit
    Lemelin, Valery
    Hoos, Lizbeth
    Benjannet, Suzanne
    Seidah, Nabil G.
    Davis, Harry R., Jr.
    Couture, Patrick
    JOURNAL OF LIPID RESEARCH, 2011, 52 (03) : 558 - 565
  • [7] Oxysterols are PPARdelta agonists and activate NPC1L1 and ABCA1 expression in cholangiocytes
    Xia, Xuefeng
    Zhang, Wenzheng
    Xiao, Yuhua
    Gao, Dongbing
    Thosani, Nirav
    Moore, David
    LeSage, Gene D.
    HEPATOLOGY, 2006, 44 (04) : 193A - 194A
  • [8] Mutations in NPC1L1 and Coronary Heart Disease
    Mirshahi, Uyenlinh L.
    Carey, David J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (09): : 881 - 881
  • [9] NPC1L1 gene expression is down-regulated by stearic acid in CCL-241 cells
    Rodriguez-Melendez, R
    Rasmussen, HE
    Lee, JY
    Carr, TP
    FASEB JOURNAL, 2006, 20 (04): : A138 - A138
  • [10] VARIATION IN HMGCR AND NPC1L1 AND INFLAMMATORY BIOMARKERS
    Li, Jiawen
    Tang, Xiao-Fang
    Xu, Jingjing
    Liu, Ru
    Li, Yulong
    Song, Lei
    Yuan, Jinqing
    Zhao, Xueyan
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 1012 - 1012